Company financials

Agilent Technologies

Health Care Life Sciences Tools & Services Santa Clara, California Last filing Dec 22, 2025 · FY2025

                    Revenue
                    FY2025
                
$6.9B
                    
                    +6.7%
                    
                    Net income
                    FY2025
                
$1.3B
                    
                    +1.1%
                    
                    Total assets
                    FY2022
                
$10.5B
                    
                    -1.6%
                    
                    Operating cash flow
                    FY2022
                
$317.0M
                    
                    -1.2%

Balance Sheet

Assets, liabilities, and equity

31 accounts · 5 years

Total assets $10.5B

Total liabilities $5.2B

Shareholders equity $5.3B

Account	2025	2024	2023	2022	2021
Statement
BS Assets Cash	$1.8B	$1.3B	$1.6B	—	—
BS Assets Short Term Invest	$0	$0	$0	—	—
BS Assets Accts Receivable	$1.5B	$1.3B	$1.3B	—	—
BS Assets Inventory	$1.0B	$972.0M	$1.0B	—	—
BS Assets Prepaid Expenses	$293.0M	$334.0M	$274.0M	—	—
BS Assets Other Current Assets	$293.0M	$334.0M	$274.0M	—	—
BS Assets Total Current	$4.6B	$4.0B	$4.2B	—	—
BS Assets PPE	$2.0B	$1.8B	$1.3B	—	—
BS Assets Op Lease ROU	$183.0M	$177.0M	$154.0M	—	—
BS Assets Goodwill	$4.5B	$4.5B	$4.0B	—	—
BS Assets Intangible Assets	$445.0M	$547.0M	$475.0M	—	—
BS Assets LT Investments	$133.0M	$175.0M	$164.0M	—	—
BS Assets Other Noncurrent	$1.1B	$910.0M	$708.0M	—	—
BS Assets Total	$12.7B	$11.8B	$10.8B	—	—
BS Liab Accts Payable	$570.0M	$540.0M	$418.0M	—	—
BS Liab Accrued Liab	$443.0M	$520.0M	$444.0M	—	—
BS Liab Deferred Rev Current	$624.0M	$544.0M	$505.0M	—	—
BS Liab Current Debt	$304.0M	$45.0M	$0	—	—
BS Liab Total Current	$2.3B	$1.9B	$1.6B	—	—
BS Liab Long Term Debt	$3.0B	$3.3B	$2.7B	—	—
BS Liab Deferred Rev LT	$624.0M	$544.0M	$505.0M	—	—
BS Liab Other Noncurrent	$463.0M	$578.0M	$477.0M	—	—
BS Liab Total	$6.0B	$5.9B	$4.9B	—	—
BS Equity Preferred Stock	$0	$0	$0	—	—
BS Equity Common Stock	$3.0M	$3.0M	$3.0M	—	—
BS Equity APIC	$5.6B	$5.5B	$5.4B	—	—
BS Equity Retained Earnings	$1.4B	$750.0M	$782.0M	—	—
BS Equity Treasury Stock	$0	$0	$0	—	—
BS Equity AOCI	$-226.0M	$-305.0M	$-327.0M	—	—
BS Equity Total	$6.7B	$5.9B	$5.8B	—	—
BS Equity Total Liab and Equity	$12.7B	$11.8B	$10.8B	—	—

Income Statement

Revenue, expense, and profitability

20 accounts · 5 years

Revenue $6.9B

Operating income $1.5B

Net income $1.3B

Account	2025	2024	2023	2022	2021
Statement
IS Revenue Total	$6.9B	$6.5B	$6.8B	—	—
IS Expense COGS	$3.3B	$3.0B	$3.4B	—	—
IS Expense Rn D	$455.0M	$479.0M	$481.0M	—	—
IS Expense SGA	$1.7B	$1.6B	$1.6B	—	—
IS Expense DA	$288.0M	$257.0M	$271.0M	—	—
IS Expense SBC	$128.0M	$129.0M	$111.0M	—	—
IS Expense Restructuring	$82.0M	$76.0M	$46.0M	—	—
IS Expense Total Opex	$5.5B	$5.0B	$5.5B	—	—
IS Operating Income	$1.5B	$1.5B	$1.4B	—	—
IS Interest Income	$62.0M	$80.0M	$51.0M	—	—
IS Interest Expense	$112.0M	$96.0M	$95.0M	—	—
IS Other Nonop Inc Exp	$6.0M	$49.0M	$33.0M	—	—
IS Pre Tax Income	$1.4B	$1.5B	$1.3B	—	—
IS Tax Expense	$132.0M	$232.0M	$99.0M	—	—
IS net Income	$1.3B	$1.3B	$1.2B	—	—
IS Comprehensive Income	$1.4B	$1.3B	$1.3B	—	—
IS EPS Basic	$5	$4	$4	—	—
IS EPS Diluted	$5	$4	$4	—	—
IS Shares Basic	$284.0M	$290.0M	$294.0M	—	—
IS Shares Diluted	$285.0M	$291.0M	$296.0M	—	—

Cash Flow Statement

Operating, investing, and financing flows

22 accounts · 5 years

Operating cash flow $317.0M

Investing cash flow $291.0M

Financing cash flow $1.3B

Account	2025	2024	2023	2022	2021
Statement
CF Ops net Income	$1.3B	$1.3B	$1.2B	—	—
CF Ops DA	$288.0M	$257.0M	$271.0M	—	—
CF Ops SBC	$128.0M	$129.0M	$111.0M	—	—
CF Ops Deferred Tax	$-130.0M	$-64.0M	$-56.0M	—	—
CF Ops Working Capital	$833.0M	$522.0M	$190.0M	—	—
CF Ops net Cash	$1.6B	$1.8B	$1.8B	—	—
CF Inv Capex	$407.0M	$378.0M	$298.0M	—	—
CF Inv Acquisitions	$-4.0M	$862.0M	$51.0M	—	—
CF Inv Purchase Investments	$0	$5.0M	$8.0M	—	—
CF Inv net Cash	$-394.0M	$-1.3B	$-310.0M	—	—
CF Fin Debt Issuance	$4.0M	$1.2B	$0	—	—
CF Fin Debt Repayment	$3.0M	$600.0M	$0	—	—
CF Fin Share Repurchases	$425.0M	$1.1B	$575.0M	—	—
CF Fin Dividends	$282.0M	$274.0M	$265.0M	—	—
CF Fin Stock Issuance	$72.0M	$77.0M	$67.0M	—	—
CF Fin Tax Withholding	$29.0M	$30.0M	$54.0M	—	—
CF Fin Other	$0	$0	$0	—	—
CF Fin net Cash	$-715.0M	$-752.0M	$-930.0M	—	—
CF FX Effect	$9.0M	$-2.0M	$5.0M	—	—
CF net Change	$459.0M	$-261.0M	$537.0M	—	—
CF Cash Begin	$1.8B	$1.3B	$1.6B	—	—
CF Cash End	$1.8B	$1.3B	$1.6B	—	—

Stock Data

One-year price and volume history

Cached market data

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

One-year price and volume history

Recent price history